CD40 ligand triggers interleukin-6 mediated B cell differentiation

Leukemia Research

Volumn 20, Issue 6, 1996, Pages 507-515

  Urashima, Mitsuyoshi ^a   Chauhan, Dharminder ^a   Hatziyanni, Maria ^a   Ogata, Atsushi ^a   Hollenbaugh, Diane ^b,c   Aruffo, Alejandro ^b,c   Anderson, Kenneth C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

B cell; CD40 ligand; IL 10; IL 4; Interleukin 6 (IL 6)

Indexed keywords

CD20 ANTIGEN; CD38 ANTIGEN; CD40 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LIGAND; LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN PRODUCTION; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL;

EID: 0030176282     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(95)00098-4     Document Type: Article

References (57)

1. 1. Matsusha K., Procopio A., Abe H., Scalaa G., Ortaldo J. R. & Oppenheim J. J. (1985) Production of interleukin-1 activity by normal human peripheral blood B lymphocytes. J. Immunol. 135, 1132.
2. 2. Gordon J., Ley S. C, Melaamed M. D., English L. S. & Hughes-Jones N. C. (1984) Immortalized B lymphocytes produce B cell growth factor. Nature 310, 145.
3. 3. Muraguchi A., Nishimoto H., Kawamura N., Hori A. & Kishimoto T. (1986) B cell-derived BCGF functions as autocrine growth factor(s) in normal and transformed B lymphocytes. J. Immunol. 137, 179.
4. 4. Horii Y., Muraguchi A., Suematsu S., Matsuda T., Yoshizaki K., Hirano T. & Kishimoto T. (1988) Regulation of BSF-2/IL-6 production by human mononuclear cells. J. Immunol. 141, 1529.
5. 5. Freeman G. J., Freedman A. S., Rabinowe S. N., Segil J. M., Horowitz J., Rosen K., Whitman J. F. & Nadler L. M. (1989) Interleukin-6 gene expression in normal and neoplastic B cells. J. Clin. Invest. 83, 1512.
6. 6. Matthes T., Werner-Favre C., Tang H., Zhang X., Kindler V. & Zubler R. H. (1993) Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor α, interleukin (IL)-6, IL-10, and transforming growth factor β1 mRNAs. J. Expl Med. 178, 521.
7. 7. Kehrl J. H., Roberts A. B., Wakefield L. M., Jakowlew S., Sporn M. B. & Fauci A. F. (1986) Transforming growth factor B is an important immunoregulatory protein for human B lymphocytes. J. Immunol. 137, 3855.
8. 8. Uckun F. M. (1990) Regulation of human B cell ontogeny. Blood 76, 1908.
9. 9. Anderson K. C., Boyd A. W., Fisher D. C., Slaughenhoupt B., Groopman J. E., O'Hara C. J., Daley J. F., Schlossman S. F. & Nadler L. M. (1985) Isolation and functional analysis of human B cell populations. I. Characterization of the B1+B2+ and B1+B2-subsets. J. Immunol. 134, 820.
10. 10. Anderson K. C., Bates M. P., Slaughenhoupt B. L., Pinkus G. S., Schlossman S. F. & Nadler L. M. (1984) Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood 63, 1424.
11. 11. Anderson K. C., Morimoto C., Paul S. R., Chauhan D., Williams D., Cochran M. & Barut B. A. (1992) Interleukin-11 promotes accessory cell-dependent B cell differentiation in humans. Blood 80, 2797.
12. 12. Tanner J. E. & Tosato G. (1992) Regulation of B cell growth and immunoglobulin gene transcription by interleukin-6. Blood 79, 452.
13. 13. Clark E. A. & Ledbetter J. A. (1994) How B and T cells talk to each other. Nature 367, 425.
14. 14. Geha R. S. & Rosen F. S. (1994) The genetic basis of immunoglobulin-class switching. N. Engl. J. Med. 130, 1008.
15. 15. Guinan E. C., Gribben J. G., Boussiotis V. A., Freeman G. J. & Nadler L. M. (1994) Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 84, 3261.
16. 16. Armitage R. J., Tough T. W., Macduff B. M., Fanslow W. C., Spriggs M. K., Ramsdell F. & Alderson M. R. (1993) CD40 ligand is a T cell growth factor. Eur. J. Immunol. 23, 2326.
17. 17. Hodgkin P. D., Yamashita L. C., Coffman R. L. & Kehry M. R. (1990) Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. J. Immunol. 145, 2025.
18. 18. Noelle R. J., Roy M., Shepherd D. M., Stamenkovic I., Ledbetter J. A. & Aruffo A. (1992) A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. natn. Acad. Sci. USA 89, 6550.
19. 19. Freeman G. J., Freeman A. S., Segil J. M., Lee G., Whitman J. F. & Nadler L. M. (1989) B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143, 2714.
20. 20. Pellat-Deceunynck C, Bataille R., Robillard N., Harousseau J.-L., Rapp M.-J., Juge-Morineau N., Wijdenes J. & Amiot M. (1994) Expression of CD28 and CD40 in human myeloma cells: a comparable study with normal plasma cells. Blood 84, 2597.
21. 21. Clark E. & Ledbetter J. (1986) Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc. natn Acad. Sci. USA 83, 4494.
22. 22. Bahchereau J. & Rousset F. (1991) Growth of human B lymphocytes in the CD40 system. Nature 359, 678.
23. 23. Armitage R. J., Fanslow W. C., Strockbine L., Sato T. A., Clifford K. N., Macduff B. M., Anderson D. M., Gimpel S. D., Smith T. D., Maliszewsski C. R., Clark E. A., Smith C. A., Grabstein K. H., Cosman D. & Spriggs M. K. (1992) Molecular and biological characterization of a murine ligand for CD40. Nature 357, 80.
24. 24. Hollenbaugh D., Grosmaire L. S., Kullas C. D., Chalupny N. J., Braesch-Anderson S., Noelle R. J., Stamenkovic I., Ledbetter J. A. & Aruffo A. (1992) The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO 11, 4313.
25. 25. Spriggs M. K., Sato T. A., Maliszewski C. R. & Fanslow W. C. (1992) Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Expl Med. 176, 1543.
26. 26. Liu Y. J., Joshua D. E., Wiliams G. T., Smith C. A., Gordon J. & MacLennon I. C. M. (1989) Mechanism of antigen-driven selection in germinal centers. Nature 342, 9292.
27. 27. Tsubata T., Wu J. & Honjo T. (1993) B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 364, 645.
28. 28. Banchereau J., Paoli P., Valle A., Garcia E. & Rousset F. (1900) Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 250, 70.
29. 29. Jabara H., Fu S. M., Geha R. S. & Vercelli D. (1990) CD40 and IgE: Synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Expl Med. 172, 1861.
30. 30. Armitage R. J., Macduff B. M., Spriggs M. K. & Fanslow W. C. (1993) Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol. 150, 3671.
31. 31. Nonoyama S., Hollenbaugh D., Aruffo T., Ledbetter J. A. & Ochs H. O. (1993) B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J. Expl Med. 178, 1097.
32. 32. Jabara H. H., Fu S. M., Geha R. S. & Vercelli D. (1990) CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin-4 in the induction of IgE synthesis by highly purified human B cells. J. Expl Med. 172, 1861.
33. 33. Defrance T., Vanberviet B., Brriere F., Durand I., Rousset F. & Banchereau J. (1992) Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Expl Med. 175, 671.
34. 34. Chauhan D., Uchiyama H., Urashima M., Yamamoto K. & Andersen K. C. (1996) NFkB motif regulates myeloma cell adhesion-related interleukin-6 expression in bone marrow stromal cells involves activation of NF-KB. Blood 87, 1104.
35. 35. Urashima M., Chauhan D., Uchiyama H., Freeman G. J. & Anderson K. C. (1995) CD40 ligand triggered IL-6 secretion in multiple myeloma. Blood 85, 1903.
36. 36. Chauhan D., Kharbanda S., Uchiyama H., Urashima M., Sen J., Fuguso R., Kufe D. W. & Anderson K. C. (1994) Identification of upstream signals regulating interleukin-6 gene expression during in vitro treatment of human B cells with pokeweed mitogen. Blood 84, 2243.
37. 37. Taga T., Kawanishi Y., Hardy R. R., Hirano T. & Kishimoto T. (1987) Receptors for B cell stimulatory factor 2: quantitation, specificity, distribution, and regulation of their expression. J. Expl Med. 166, 967.
38. 38. Kishimoto T., Akira S. & Taga T. (1992) Interleukin-6 and its receptor: a paradigm for cytokines. Science 258, 593.
39. 39. Clark E. A. & Shu G. (1990) Association between IL-6 and CD40 signaling: IL-6 induces phosphorylation of CD40 receptors. J. Immunol. 145, 1400.
40. 40. Berberich I., Shu G. L. & Clark E. A. (1994) Cross-linking CD40 on B cells rapidly activates nuclear factor kB. J. Immunol. 153, 4357.
41. 41. Smeland E. B., Blomhoff H. K., Funderud S., Shalaaby M. R. & Espevik T. (1989) Interleukin 4 induces selective production of interleukin-6 from normal human B lymphocytes. J. Expl Med. 170, 1463.
42. 42. Vercelli D., Jabara H. H., Arai K. -I., Yokoto T. & Gaha R. S. (1989) Endogenous interleukin-6 plays an obligatory role in interleukin-4 dependent human IgE synthesis. Eur. J. Immunol. 19, 1419.
43. 43. Suematsu S., Matsuda T., Aozasa K., Akira S., Nakano N., Ohno S., Miyazaki J.-I., Yamamura K.-I., Hirano T. & Kishimoto T. (1989) IgG1 plasmacytosis in interleukin-6 transgenic mice. Proc. natn. Acad. Sci. USA 86, 7574.
44. 44. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernage R., Bluethmann H. & Kohler G. (1994) Impaired immune and acute-phase responses in interleukin-6 deficient mice. Nature 368, 339.
45. 45. Van den Eertwegh A. J .M., Noelle R. J., Roy M., Shepherd D., Aruffo A., Ledbetter J. A., Boersma W. J. A. & Claassen E. (1993) In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T B cell interaction. J. Expl Med. 178, 1555.
46. 46. Brieva J. A., Roldan J. A., Delasen M.-L. & Rodriguez C. (1991) Human in vivo-induced spontaneous IgG-secreting cells from tonsil, blood and bone marrow exhibit different phenotype and functional level of maturation. Immunology 72, 580.
47. 47. Renshaw B. R., Fanslow W. C. III, Armitage R. J., Cambell K. A., Liggitt D., Wright B., Davison B. L. & Maliszewski C. R. (1994) J. Expl Med. 180, 1889.
48. 48. Aruffo A., Farrington M., Hollenbaugh D., Li X., Milatovich A., Nonoyama S., Bajorath J., Grosmaire L. S., Stenkamp R., Neubauer M., Roberts R. L., Noelle R. J., Ledbetter J. A., Francke U. & Ochs H. D. (1993) The CD40 ligand, gp 39, is defective in activated T cells from patients with X-linked Hyper Ig-M Syndrome. Cell 72, 291.
49. 49. Johnson P. W. M., Watt S. M., Betts D. R., Davies D., Jordan S., Noroton A J. & Lister T. A. (1993) Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood 82, 1848.
50. 50. Crawford D .H. & Catovsky D. (1993) In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40. Immunology 80, 40.
51. 51. Kawano M, Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tanabe O. & Kishimoto T. (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myeloma. Nature 332, 83.
52. 52. Barut B. A., Zon L. I., Cochran M. K., Paul S. R., Chauhan D., Mohrbacher A., Fingeroth J. & Anderson K. C. (1992) Role of interleukin-6 in the growth of myeloma derived cell lines. Leukemia Res. 16, 951.
53. 53. Uchiyama H., Barut B. A., Mohrbacher A. F., Chauhan D. & Anderson K. C. (1993) Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulate interleukin-6 secretion. Blood 82, 3712.
54. 54. Westendorf J. F., Ahmann G. J., Armitage R. J., Spriggs M. K., Lust J. A., Greipp P. R., Katzmann J. A. & Jelinek D. F. (1994) CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J. Immunol. 152, 117.
55. 55. Tong A. W., Zhang B Q., Mues G., Solano M., Hanson T. & Stone M. J. (1994) Anti-CD40 antibody-binding modulates human multiple myeloma clonogenicity in vitro. Blood 84, 3026.
56. 56. Blay J. -Y., Burdin N., Rousset F., Lenoir G., Biron P., Philip T., Banchereau J. & Favrot M. C. (1993) Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood 82, 2169.
57. 57. Merville P., Rousset F., Banchereau J., Klein B. & Bataille R. (1992) Serum interleukin 10 in early stage multiple myeloma. Lancet 340, 1544.